Dietary restriction of L-methionine, an essential amino acid, exerts potent antitumor effects on L-methioninedependent cancers. However, dietary restriction of L-methionine has not been practical for human therapy because of the problem with the administration of L-methionine concentration in foods. Here, a thermophilic methionine γ-lyase (MGL), that catalyzes the cleavage of the C−S bond in L-methionine to produce α-ketobutyric acid, methanethiol, and ammonia was engineered from human cystathionine γ-lyase and almost completely depleted L-methionine at 65 °C, a temperature that accelerates the volatilization of methanethiol and its oxidation products. The high efficiency of L-methionine lysis may be attributed to the cooperative fluctuation and moderate the structural rigidity of 4 monomers in the thermophilic MGL, which facilitates L-methionine access to the entrance of the active site. Experimental diets treated with thermophilic MGL markedly inhibited prostate tumor growth in mice, and in parallel, the in vivo concentrations of L-methionine, its transformation product L-cysteine, and the oxidative stress indicator malondialdehyde significantly decreased. These findings provide a technology for the depletion of L-methionine in foods with an engineered thermophilic MGL, which efficiently inhibits tumor growth in mice.